Google Übersetzer
About
Surenano Science Ltd (CN:SURE) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 24 2026
SureNano Science Initiates FDA Stage GLP Toxicology and Pharmacology Studies for GLP GEP-44 and Enters Discussions to Acquire Ibogaine Formulation IP Portfolio
Dec 12 2025
SureNano Announces Stock Option Grant
Dec 10 2025
SureNano Announces Closing of $1,250,000 Private Placement
Nov 19 2025
SureNano Announces Non-Binding Letter of Intent to Negotiate Proposed Transaction of GlucaPharm Inc. for GLP-1 Drug Development
Nov 5 2025
SureNano Announces Private Placement
Financials
Revenue
CA$0
Market Cap
CA$9.83 M
EPS
-0.01